117 related articles for article (PubMed ID: 7490264)
21. Expression of leukemia inhibitory factor and its receptor in preimplantation embryos.
Chen HF; Shew JY; Ho HN; Hsu WL; Yang YS
Fertil Steril; 1999 Oct; 72(4):713-9. PubMed ID: 10521116
[TBL] [Abstract][Full Text] [Related]
22. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation.
Estrov Z; Samal B; Lapushin R; Kellokumpu-Lehtinen P; Sahin AA; Kurzrock R; Talpaz M; Aggarwal BB
J Interferon Cytokine Res; 1995 Oct; 15(10):905-13. PubMed ID: 8564713
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
[TBL] [Abstract][Full Text] [Related]
24. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
25. Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation.
Malaval L; Aubin JE
J Cell Biochem Suppl; 2001; Suppl 36():63-70. PubMed ID: 11455571
[TBL] [Abstract][Full Text] [Related]
26. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
[TBL] [Abstract][Full Text] [Related]
27. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
28. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution.
Hilton DJ; Nicola NA
J Biol Chem; 1992 May; 267(15):10238-47. PubMed ID: 1587813
[TBL] [Abstract][Full Text] [Related]
29. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
Hui W; Bell MC; Carroll GJ; Layton MJ
Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix.
Mereau A; Grey L; Piquet-Pellorce C; Heath JK
J Cell Biol; 1993 Aug; 122(3):713-9. PubMed ID: 8335694
[TBL] [Abstract][Full Text] [Related]
32. Changes in the early differentiation pathway of monoparental embryonic stem cells is not affected by the expression of LIF receptors.
Garcia Tobalina R; Uranga JA; Aréchaga J
Int J Dev Biol; 1996; Suppl 1():213S-214S. PubMed ID: 9087766
[No Abstract] [Full Text] [Related]
33. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.
Owczarek CM; Layton MJ; Metcalf D; Lock P; Willson TA; Gough NM; Nicola NA
EMBO J; 1993 Sep; 12(9):3487-95. PubMed ID: 8253075
[TBL] [Abstract][Full Text] [Related]
34. Specific binding of leukemia inhibitory factor to murine myoblasts in culture.
Bower J; Vakakis N; Nicola NA; Austin L
J Cell Physiol; 1995 Jul; 164(1):93-8. PubMed ID: 7790402
[TBL] [Abstract][Full Text] [Related]
35. The soluble interleukin-6 receptor.
Rose-John S; Ehlers M; Grötzinger J; Müllberg J
Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
[No Abstract] [Full Text] [Related]
36. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
[TBL] [Abstract][Full Text] [Related]
37. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
[TBL] [Abstract][Full Text] [Related]
39. Three different cDNAs encoding mouse D-factor/LIF receptor.
Tomida M; Yamamoto-Yamaguchi Y; Hozumi M
J Biochem; 1994 Mar; 115(3):557-62. PubMed ID: 8056772
[TBL] [Abstract][Full Text] [Related]
40. The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy.
Pitard V; Lorgeot V; Taupin JL; Aubard Y; Praloran V; Moreau JF
Eur Cytokine Netw; 1998 Dec; 9(4):599-605. PubMed ID: 9889403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
